Timothy Eugene Sullivan, Chief Financial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 1,812 shares at $64.14 ($116K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
Open-market sale of $116k APLS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.14 | 906 | $58K | 50.0% |
| 2 | $64.14 | 906 | $58K | 50.0% |
| Total | $64.14 avg | 1,812 | $116K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $86K | — | Filing → |
| APLS | SELL | 2025-10-23 | $280K | — | Filing → |
| APLS | SELL | 2025-09-10 | $2.1M | — | Filing → |